How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

481 results for

Prevention of Vector-borne Infection

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Preparing HIV-infected children and adolescents for travel

/pediatricguidelines.pdf. 5. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Last updated June 2017 [update in progress]. http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. 6. Launay O (...) Preparing HIV-infected children and adolescents for travel 1 Guideline: Preparing HIV-infected children and adolescents for travel Authors: Natalie Prevatt Date of preparation: February 2017 Next review date: February 2019 Contents Summary 2 Introduction to the guideline 2 General travel health and safety advice for travel 2 Traveller’s diarrhoea: prevention and treatment 4 Malaria prevention 4 Personal protection 6 Chemoprophylaxis 6 Important interactions between antimalarials and ART 7

2018 The Children's HIV Association

22. Prevention and Control Strategies to Counter Dengue Virus Infection Full Text available with Trip Pro

Prevention and Control Strategies to Counter Dengue Virus Infection Dengue is currently the highest and rapidly spreading vector-borne viral disease, which can lead to mortality in its severe form. The globally endemic dengue poses as a public health and economic challenge that has been attempted to suppress though application of various prevention and control techniques. Therefore, broad spectrum techniques, that are efficient, cost-effective, and environmentally sustainable, are proposed (...) vectors, has improved the efficacy of the traditional strategies. Although a large-scale vector control strategy can be limited, innovative vaccine candidates have provided evidence for promising dengue prevention measures. The use of tetravalent dengue vaccine (CYD-TDV) has been the most effective so far in treating dengue infections. Nonetheless, challenges and limitation hinder the progress of developing integrated intervention methods and vaccines; while the improvement in the latest techniques

2017 Frontiers in cellular and infection microbiology

23. Non-vector-borne transmission of Zika virus: A systematic review. (Abstract)

Non-vector-borne transmission of Zika virus: A systematic review. Increasing numbers of confirmed cases of Zika virus (ZIKV) infection resulting from non-mosquito-borne transmission have been reported.We performed a systematic literature review (PRISMA guidelines) on intrauterine, intrapartum, sexual and animal bite ZIKV transmission. The presence of the virus in breast milk, urine, saliva and blood transfusions was also reviewed.The search resulted in 285 papers of possible relevance, of which (...) and urine and data on saliva, animal bites, transplantation, needlestick injury and laboratory work are inconclusive.Our systematic analysis shows that non-vector-borne ZIKV transmission plays a role in the spread of ZIKV and has great societal impact. It has important public health implications for the prevention and control of ZIKV globally and will be a basis for policy and further research.Copyright © 2016 Elsevier Ltd. All rights reserved.

2016 Travel medicine and infectious disease

24. Global spread and impacts of emerging vector-borne diseases Full Text available with Trip Pro

Global spread and impacts of emerging vector-borne diseases 29769978 2018 11 14 1188-4169 42 10 2016 Oct 06 Canada communicable disease report = Releve des maladies transmissibles au Canada Can. Commun. Dis. Rep. Global spread and impacts of emerging vector-borne diseases. 198-199 Kulkarni M A MA School of Epidemiology, Public Health & Preventive Medicine, University of Ottawa, Ottawa, ON. eng Journal Article 2016 10 06 Canada Can Commun Dis Rep 9303729 1188-4169 Conflict of interest: None

2016 Canada Communicable Disease Report

25. Enhancing Decision Support for Vector-Borne Disease Control Programs—The Disease Data Management System Full Text available with Trip Pro

Medicine, Liverpool, United Kingdom. Coleman Michael M Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom. eng Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. 2016 02 18 United States PLoS Negl Trop Dis 101291488 1935-2727 IM Animals Communicable Disease Control methods Communicable Diseases diagnosis therapy Decision Support Techniques Disease Transmission, Infectious prevention & control Disease Vectors (...) Enhancing Decision Support for Vector-Borne Disease Control Programs—The Disease Data Management System 26890287 2016 06 08 2019 02 02 1935-2735 10 2 2016 Feb PLoS neglected tropical diseases PLoS Negl Trop Dis Enhancing Decision Support for Vector-Borne Disease Control Programs--The Disease Data Management System. e0004342 10.1371/journal.pntd.0004342 Thomsen Edward K EK Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom. Deb Rinki M RM Department

2016 PLoS neglected tropical diseases

26. Control of Vector-Borne Human Parasitic Diseases Full Text available with Trip Pro

Control of Vector-Borne Human Parasitic Diseases 28090535 2017 01 30 2018 11 13 2314-6141 2016 2016 BioMed research international Biomed Res Int Control of Vector-Borne Human Parasitic Diseases. 1014805 10.1155/2016/1014805 Genta Fernando A FA 0000-0001-9558-1116 Oswaldo Cruz Institute-Oswaldo Cruz Foundation (IOC-FIOCRUZ), Av. Brasil 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil; National Institute of Science and Technology for Molecular Entomology (INCT-EM), Av. Carlos Chagas Filho (...) Parasitologia Médica, Global Health & Tropical Medicine, GHTM, Instituto de Higiene e Medicina Tropical, IHMT, Universidade Nova de Lisboa, Rua da Junqueira 100, 1349-008 Lisbon, Portugal. Gomes Bruno B 0000-0003-3877-2359 Department of Vector Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK. eng Editorial 2016 12 20 United States Biomed Res Int 101600173 IM Animals Arthropod Vectors Humans Parasitic Diseases epidemiology prevention & control transmission 2016 10 03 2016

2016 BioMed research international

27. Spatial Repellent Products for Control of Vector Borne Diseases

Enrollment : 0 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) Primary Purpose: Prevention Official Title: Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Zambia Study Start Date : March 2016 Actual Primary Completion Date : April 2016 Actual Study Completion Date : April 2016 Resource links provided by the National Library of Medicine related topics: resources: Arms (...) Spatial Repellent Products for Control of Vector Borne Diseases Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Zambia (SR-M-ZM) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more

2015 Clinical Trials

28. Bacterial and protozoal agents of canine vector-borne diseases in the blood of domestic and stray dogs from southern Portugal Full Text available with Trip Pro

by DNA sequencing, including one animal confirmed with both A. platys and H. canis. Furthermore, Wolbachia spp. was amplified in blood from four dogs. None of the tested dogs was positive by PCR for Bartonella spp. or Babesia spp.The molecular identification of CVBD agents in southern Portugal, some of them with zoonotic concern, reinforces the importance to alert the veterinary community, owners and public health authorities to prevent the risk of transmission of vector-borne pathogens among dogs (...) Bacterial and protozoal agents of canine vector-borne diseases in the blood of domestic and stray dogs from southern Portugal The so-called canine vector-borne diseases (CVBD) are caused by a wide range of pathogens transmitted by arthropods. In addition to their veterinary importance, many of these canine vector-borne pathogens can also affect the human population due to their zoonotic potential, a situation that requires a One Health approach. As the prevalence of vector-borne pathogens

2015 Parasites & vectors

29. Bites and mites: prevention and protection of vector-borne disease. (Abstract)

Bites and mites: prevention and protection of vector-borne disease. Vector-borne diseases (VBDs) are difficult to prevent and control because it is hard to predict the complex habits of mosquitoes, ticks and fleas; most vector-borne viruses or bacteria infect animals as well as humans, which further adds to this difficulty. Thus, prevention is the best protection against VBD.Vaccines are available for yellow fever, Japanese encephalitis and tick-borne encephalitis and several vaccines (...) are in clinical trials for dengue fever. Antimalarial intermittent preventive therapy (sulfadoxine-pyrimethamine) and insecticide-treated mosquito nets are associated with a decreased risk of neonatal mortality and lower birth-weight. Permethrin-impregnated clothing for the prevention of tick bites has been shown effective in reducing tick bites.Much progress has been made in terms of development of preventive vaccines and medicines, but there is more work that needs to be done. Efforts still need to continue

2013 Current Opinion in Pediatrics

30. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology Full Text available with Trip Pro

, the pediatric needs of specimen management are also emphasized. There is intentional redundancy among the tables and sections, as many agents and assay choices overlap. The document is intended to serve as a guidance for physicians in choosing tests that will aid them to quickly and accurately diagnose infectious diseases in their patients. , , , , Contents Introduction and Executive Summary I. Bloodstream Infections and Infections of the Cardiovascular System II. Central Nervous System Infections III (...) A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious

2018 Infectious Diseases Society of America

31. Vector-borne diseases in Europe: far more than Zika virus

of travellers returning from countries where malaria is endemic. This infectious disease, once eradicated from our territories due to the effectiveness of control campaigns during the 1950s and 1960s, is . Vector-borne diseases are a reflection of the complex world in which we live and constitute a global challenge that requires global solutions, including: the reinforcement of national and international coordination mechanisms; the development of preparedness and response plans at points of origin (...) Vector-borne diseases in Europe: far more than Zika virus Vector-borne diseases in Europe: far more than Zika virus - The BMJ ---> Certain emerging vector-borne diseases are . Two years ago , a disease that most Spaniards—including doctors—had not even heard of, but which has already become . Now Zika virus disease is gaining broad interest in the wake of its and in the detection of imported cases, including in the and . Without dismissing Zika as a public health priority, we may need a broader

2016 The BMJ Blog

32. Emerging and re-emerging human infectious diseases: A systematic review of the role of wild animals with a focus on public health impact

new infectious agents with unknown virulent potential. In conclusion, the monitoring of these diseases and adequate preparation for possible epidemics and pandemics are fundamental conditions for the mitigation of their future impact. The zoonotic threat of these etiological agents and the impact on public health can be enormous as shown by the ongoing epidemic of 2019 novel coronavirus (2019- nCoV) infections. "> Impact Factor 2018: 1.772 (@Clarivate Analytics) 5-Year Impact Factor: 1.772 (...) of their future impact. The zoonotic threat of these etiological agents and the impact on public health can be enormous as shown by the ongoing epidemic of 2019 novel coronavirus (2019- nCoV) infections. Keywords: Zoonosis; Epidemics; 2019-nCoV; Virology; Epidemiology How to cite this article: Cupertino MC, Resende MB, Mayer NA, Carvalho LM, Siqueira-Batista R. Emerging and re-emerging human infectious diseases: A systematic review of the role of wild animals with a focus on public health impact. Asian Pac J

2020 Covid-19 Ad hoc papers

33. Management of Dengue Infection in Adults

postgraduates and undergraduates, and allied f. health students) Patients and carers g. HEALTHCARE SETTINGS Outpatient, inpatient and community settings inclusive of private healthcare facilities. iv8 9 CPG Management of Dengue Infection In Adults (Third Edition) 2015 Dr. Ahmad Tajuddin Mohamad Nor Consultant Emergency Medicine Specialist Hospital Tengku Ampuan Rahimah Dr. Rose Nani Mudin Head of Vector - Borne Diseases Disease Control Division, MoH Dr. Anilawati Mat Jelani Infectious Disease Physician (...) 21 26 27 28 30 37 40 42 Levels of Evidence & Formulation of Recommendation Guidelines Development and Objectives Guidelines Development Group Review Committee External Reviewers i ii v vi vii No. Title Page4 CPG Management of Dengue Infection In Adults (Third Edition) 2015 5 43 43 43 44 46 56 57 58 60 61 62 63 64 65 66 67 68 68 68 No. Title Page PREVENTION OF DENGUE TRANSMISSION IN HOSPITALS 10. VACCINATION 11. FOOD AND SUPPLEMENTS 12. IMPLEMENTING THE GUIDELINES 13. REFERENCES 14. Appendix 1

2015 Ministry of Health, Malaysia

34. Legal aspects of public health: Difficulties in controlling vector-borne and zoonotic diseases in Brazil. (Abstract)

Legal aspects of public health: Difficulties in controlling vector-borne and zoonotic diseases in Brazil. In recent years, vector-borne and zoonotic diseases have become a major challenge for public health. Dengue fever and leptospirosis are the most important communicable diseases in Brazil based on their prevalence and the healthy life years lost from disability. The primary strategy for preventing human exposure to these diseases is effective insect and rodent control in and around the home (...) . However, health authorities have difficulties in controlling vector-borne and zoonotic diseases because residents often refuse access to their homes. This study discusses aspects related to the activities performed by Brazilian health authorities to combat vector-borne and zoonotic diseases, particularly difficulties in relation to the legal aspect, which often impede the quick and effective actions of these professionals. How might it be possible to reconcile the need to preserve public health

2014 Acta Tropica

35. Spatial Repellent Products for the Control of Vector Borne Diseases

Intervention Model: Parallel Assignment Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) Primary Purpose: Prevention Official Title: Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Tanzania Study Start Date : February 2016 Actual Primary Completion Date : April 2016 Actual Study Completion Date : April 2016 Resource links provided by the National Library of Medicine related topics: resources: Arms and Interventions Go to Arm Intervention (...) Spatial Repellent Products for the Control of Vector Borne Diseases Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Tanzania - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more

2014 Clinical Trials

36. Spatial Repellent Products for the Control of Vector Borne Diseases

: 0 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) Primary Purpose: Prevention Official Title: Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Kenya Study Start Date : June 2016 Actual Primary Completion Date : July 2016 Actual Study Completion Date : July 2016 Resource links provided by the National Library of Medicine related topics: resources: Arms (...) Spatial Repellent Products for the Control of Vector Borne Diseases Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Kenya - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more

2014 Clinical Trials

37. Spatial Repellent Products for Control of Vector Borne Diseases

Intervention Model: Parallel Assignment Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) Primary Purpose: Prevention Official Title: Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Indonesia Actual Study Start Date : May 2015 Actual Primary Completion Date : April 15, 2018 Actual Study Completion Date : April 15, 2018 Resource links provided by the National Library of Medicine related topics: resources: Arms and Interventions Go to Arm (...) Spatial Repellent Products for Control of Vector Borne Diseases Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Indonesia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Spatial

2014 Clinical Trials

38. Preventing Zika Virus Infections in Pregnant Women: An Urgent Public Health Priority Full Text available with Trip Pro

A. Boyle is the Director of the National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta. Lyle R. Petersen is Director of the Division of Vector-Borne Diseases, CDC, Ft. Collins, CO. Boyle Coleen A CA Beth P. Bell is the Director of the National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, Coleen A. Boyle is the Director of the National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta. Lyle (...) R. Petersen is Director of the Division of Vector-Borne Diseases, CDC, Ft. Collins, CO. Petersen Lyle R LR Beth P. Bell is the Director of the National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, Coleen A. Boyle is the Director of the National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta. Lyle R. Petersen is Director of the Division of Vector-Borne Diseases, CDC, Ft. Collins, CO. eng Editorial United

2016 American Journal of Public Health

39. Human Kinetoplastid Protozoan Infections: Where Are We Going Next? Full Text available with Trip Pro

, integrating this knowledge into effective stewardship programs to prevent vector-borne kinetoplastid infections in areas at risk of disease spreading. (...) Human Kinetoplastid Protozoan Infections: Where Are We Going Next? Kinetoplastida trypanosomatidae microorganisms are protozoan parasites exhibiting a developmental stage in the gut of insect vectors and tissues of vertebrate hosts. During the vertebrate infective stages, these parasites alter the differential expression of virulence genes, modifying their biological and antigenic properties in order to subvert the host protective immune responses and establish a persistent infection. One

2018 Frontiers in immunology

40. Association between canine leishmaniosis and Ehrlichia canis co-infection: a prospective case-control study Full Text available with Trip Pro

Association between canine leishmaniosis and Ehrlichia canis co-infection: a prospective case-control study In the Mediterranean basin, Leishmania infantum is a major cause of disease in dogs, which are frequently co-infected with other vector-borne pathogens (VBP). However, the associations between dogs with clinical leishmaniosis (ClinL) and VBP co-infections have not been studied. We assessed the risk of VBP infections in dogs with ClinL and healthy controls.We conducted a prospective case (...) . or "Candidatus Mycoplasma haematoparvum" DNA was detected in any dog. No statistical differences were found between the ClinL and controls regarding age, sex, breed, lifestyle and use of ectoparasitic prevention. A significant association between ClinL and E. canis infection (OR = 12.4, 95% CI: 1.5-106.0, P = 0.022) was found compared to controls by multivariate logistic regression. This association was confirmed using SEM, which further identified that younger dogs were more likely to be infected with each

2018 Parasites & vectors

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>